Ipratropium bromide hydrate

• CAT Number: R007423
• CAS Number: 66985-17-9
• Molecular Formula: C20H32BrNO4
• Molecular Weight: 430.38
• Purity: ≥95%
• Synonyms: [(5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;bromide;hydrate
• IUPAC Name: [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;bromide;hydrate
• InChI: InChI=1S/C20H30NO3.BrH.H2O/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;;/h4-8,14,16-19,22H,9-13H2,1-3H3;1H;1H2/q+1;;/p-1/t16-,17+,18?,19?,21?
• InChIKey: KEWHKYJURDBRMN-XFQAGIBXSA-M
• SMILES: CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.O.[Br-]

Ipratropium bromide hydrate（Cat No.:R007423）is an anticholinergic medication commonly used as a bronchodilator to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. It works by inhibiting acetylcholine receptors in the smooth muscle of the airways, leading to the relaxation of the muscles and the dilation of the bronchial passages. This helps to relieve symptoms like wheezing, shortness of breath, and coughing. Ipratropium bromide hydrate is typically administered through inhalation, either using a metered-dose inhaler or a nebulizer, and is often used in combination with other respiratory treatments.